Vyne Therapeutics Correlations

VYNE Stock

USD 2.96 0.01 0.34%

The current 90-days correlation between Vyne Therapeutics and Akari Therapeutics PLC is -0.01 (i.e., Good diversification). The correlation of Vyne Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Vyne Therapeutics Correlation With Market

Good diversification

The correlation between Vyne Therapeutics and DJI is -0.06 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Vyne Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vyne Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

For information on how to trade Vyne Stock refer to our How to Trade Vyne Stock guide.

Moving together with Vyne Stock

0.68	VTRS	Viatris	Pair Corr
0.79	ESPR	Esperion Therapeutics Buyout Trend	Pair Corr
0.74	EWTX	Edgewise Therapeutics	Pair Corr
0.65	BHC	Bausch Health Companies	Pair Corr
0.82	BMY	Bristol Myers Squibb Sell-off Trend	Pair Corr
0.68	EBS	Emergent Biosolutions	Pair Corr
0.61	WAT	Waters	Pair Corr
0.88	GILD	Gilead Sciences	Pair Corr
0.76	MNMD	Mind Medicine	Pair Corr
0.86	CPRX	Catalyst Pharmaceuticals	Pair Corr

Moving against Vyne Stock

0.89	MRK	Merck Company Fiscal Year End 6th of February 2025	Pair Corr
0.86	TAK	Takeda Pharmaceutical	Pair Corr
0.86	ZTS	Zoetis Inc	Pair Corr
0.85	HLN	Haleon plc	Pair Corr
0.83	RDY	Dr Reddys Laboratories	Pair Corr
0.82	LLY	Eli Lilly	Pair Corr
0.76	JNJ	Johnson Johnson Sell-off Trend	Pair Corr
0.76	PFE	Pfizer Inc Aggressive Push	Pair Corr
0.67	LTRN	Lantern Pharma	Pair Corr
0.65	ELAN	Elanco Animal Health	Pair Corr
0.89	ANRO	Alto Neuroscience,	Pair Corr
0.65	AMGN	Amgen Inc	Pair Corr
0.61	ANEB	Anebulo Pharmaceuticals	Pair Corr
0.48	CTLT	Catalent	Pair Corr
0.39	CVS	CVS Health Corp Sell-off Trend	Pair Corr
0.38	ABBV	AbbVie Inc Sell-off Trend	Pair Corr
0.38	SIGA	SIGA Technologies	Pair Corr
0.36	DRMAW	Dermata Therapeutics	Pair Corr
0.33	TEVA	Teva Pharma Industries	Pair Corr

Related Correlations Analysis

	AKTX	SLRX	AXLA	MGTA	HSTO	FWBI	SABS	VCNX	GOVX	CBIO
AKTX		0.12	0.86	-0.32	0.59	0.93	-0.29	0.49	0.42	-0.8	AKTX
SLRX	0.12		0.17	-0.18	0.45	0.16	-0.07	0.17	0.0	-0.36	SLRX
AXLA	0.86	0.17		-0.48	0.48	0.87	-0.61	0.33	0.25	-0.89	AXLA
MGTA	-0.32	-0.18	-0.48		-0.57	-0.3	0.31	0.34	0.51	0.52	MGTA
HSTO	0.59	0.45	0.48	-0.57		0.51	-0.13	-0.03	-0.14	-0.66	HSTO
FWBI	0.93	0.16	0.87	-0.3	0.51		-0.35	0.61	0.41	-0.79	FWBI
SABS	-0.29	-0.07	-0.61	0.31	-0.13	-0.35		-0.02	-0.08	0.57	SABS
VCNX	0.49	0.17	0.33	0.34	-0.03	0.61	-0.02		0.73	-0.19	VCNX
GOVX	0.42	0.0	0.25	0.51	-0.14	0.41	-0.08	0.73		-0.11	GOVX
CBIO	-0.8	-0.36	-0.89	0.52	-0.66	-0.79	0.57	-0.19	-0.11		CBIO
	AKTX	SLRX	AXLA	MGTA	HSTO	FWBI	SABS	VCNX	GOVX	CBIO

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

FWBI	+ 0.93	AKTX
FWBI	+ 0.87	AXLA
AXLA	+ 0.86	AKTX
GOVX	+ 0.73	VCNX
VCNX	+ 0.61	FWBI
HSTO	+ 0.59	AKTX

High negative correlations

CBIO	- 0.89	AXLA
CBIO	- 0.8	AKTX
CBIO	- 0.79	FWBI
CBIO	- 0.66	HSTO
SABS	- 0.61	AXLA
HSTO	- 0.57	MGTA

Risk-Adjusted Indicators

There is a big difference between Vyne Stock performing well and Vyne Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Vyne Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
AKTX	4.64	(1.42)	0.00	4.27	0.00	0.00	8.04	(12.59)	47.27
SLRX	4.22	(0.20)	0.00	(0.05)	0.00	0.00	9.59	(9.15)	27.43
AXLA	3.96	(1.07)	0.00	(1.22)	0.00	0.00	7.69	(9.68)	39.29
MGTA	2.62	0.04	0.00	0.19	3.40	(3.33)	5.88	(4.29)	16.99
HSTO	4.52	(1.51)	0.00	(2.40)	0.00	0.00	4.76	(4.55)	131.40
FWBI	5.73	(1.77)	0.00	6.62	0.00	0.00	8.65	(14.74)	65.42
SABS	5.31	0.17	0.02	0.41	6.20	(6.10)	13.50	(11.25)	45.73
VCNX	5.98	(0.17)	0.00	(0.23)	0.00	0.00	11.11	(14.00)	54.95
GOVX	5.62	(0.79)	0.00	(0.30)	0.00	0.00	9.26	(10.38)	77.95
CBIO	4.25	0.99	0.12	(4.73)	4.45	(6.17)	9.76	(8.33)	38.47

Vyne Therapeutics Corporate Management

Russell DPhil	VP Devel	Profile
Iain Stuart	Chief Officer	Profile
MS MD	Consultant	Profile
Subhashis MD	Senior Development	Profile
David Schuz	VP Property	Profile
Faad MD	Consultant	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC